scispace - formally typeset
M

Michael A Chapman

Researcher at University of Cambridge

Publications -  38
Citations -  5147

Michael A Chapman is an academic researcher from University of Cambridge. The author has contributed to research in topics: Medicine & Multiple myeloma. The author has an hindex of 16, co-authored 25 publications receiving 4245 citations. Previous affiliations of Michael A Chapman include British Heart Foundation & Broad Institute.

Papers
More filters
Journal ArticleDOI

Initial genome sequencing and analysis of multiple myeloma

TL;DR: The massively parallel sequencing of 38 tumour genomes and their comparison to matched normal DNAs indicates that cancer genome sequencing of large collections of samples will yield new insights into cancer not anticipated by existing knowledge.

Initial genome sequencing and analysis of multiple myeloma

TL;DR: In this paper, a massively parallel sequencing of 38 tumour genomes and their comparison to matched normal DNAs was reported, and several new and unexpected oncogenic mechanisms were suggested by the pattern of somatic mutation across the data set.
Journal ArticleDOI

Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes

TL;DR: A combined in silico and biochemical approach is used to identify binding sites and potential target genes of RE1 silencing transcription factor/neuron-restrictive silencer element (RE1/NRSE) within the human, mouse, and Fugu rubripes genomes and provides a unique whole-genome map for a given transcription factor-binding site implicated in establishing specific patterns of neuronal gene expression.
Journal ArticleDOI

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.

Katherine A Twohig, +607 more
TL;DR: In this paper, the authors compared the severity of the delta variant compared with the alpha variant by determining the relative risk of hospital attendance outcomes and found that outbreaks of the Delta variant in unvaccinated populations might lead to a greater burden on health-care services than the alpha variants.